Single-cell analysis is crucial for discovering population heterogeneity, identifying minority sub-populations of interest, and discovering unique properties of individual cells. Microfluidic systems operate on a scale comparable to cell width and are capable of manipulating single cells. Single-cell sequencing is a new and powerful technique for studying the evolution and variety of most malignancies, as well as the involvement of circulating tumour cells in cancer progression. These techniques have begun to answer critical problems in cancer biology that have been difficult to answer using bulk tumour measurements. The technology and applications of single-cell analysis have advanced dramatically in the last five years.
Recent breakthroughs in single cell technology have offered new possibilities for identifying intra-tumor cell heterogeneity, identifying unusual cell types, and determining the degree of mutation, all of which can help guide diagnoses and therapy options.
Our 4th Annual MarketsandMarkets Single-Cell Analysis Conference scheduled to be held on 6th - 7th October 2022 goal is to bring together researchers and scientists from top universities and pharmaceutical companies from all over the world to discuss significant innovations and difficulties in single-cell analysis, as well as provide a platform for academic peers to share their experiences and reveal their research articles and reports.
Professionals in Research Institutes/Universities, Pharma and Therapeutic Companies
C-Level, Vice Presidents, Presidents, Senior Directors, Directors, Global Heads, Heads, Managers, Postdocs, Senior Scientists, Senior Researchers , Professors, Bioinformatician, Computational Biologist